Results 121 to 130 of about 35,531 (245)

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis [PDF]

open access: bronze, 2021
Giovanni Palladini   +10 more
openalex   +1 more source

Multiple Myeloma : an update on disease biology and therapy [PDF]

open access: yes, 2004
Multiple myeloma is a malignancy of immunoglobulin producing plasma cells. Clinical features include bone pain due to lytic bone lesions or pathological fractures, anemia, symptomatic hypercalcemia, renal insufficiency, recurrent infections and ...
Cook, Rachel J., Dingli, David
core  

Current management of non‐amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes

open access: yes
British Journal of Haematology, EarlyView.
Daniel Cancilla   +14 more
wiley   +1 more source

Elevation of Immunoglobulin Free Light Chain and BAFF Levels Associated With Immune Activation Predicts Survival Rates in Chronic Liver Disease

open access: yesHepatology Research, Volume 55, Issue 11, Page 1531-1540, November 2025.
ABSTRACT Aims Elevated serum free light chain (FLC) and B‐cell activating factor (BAFF) levels have been reported to be associated with B‐cell activation and to serve as biomarkers reflecting disease severity in various diseases. However, limited investigation has been conducted in the context of chronic liver disease (CLD), and the aim of this study ...
Motoh Iwasa   +8 more
wiley   +1 more source

Sixty years of experience with hereditary transthyretin amyloidosis: Insights from the Swedish transthyretin amyloidosis registry

open access: yesJournal of Internal Medicine, Volume 298, Issue 5, Page 478-488, November 2025.
Abstract Background Hereditary transthyretin (ATTRv) amyloidosis was first described in Sweden in the late 1960s. Selected patient data have been collected since then and have now been transferred to a national quality registry. Methods This is the first report from SveATTR—a longitudinal Swedish web‐based registry open for TTR variant carriers and ...
Lotta Stenberg   +7 more
wiley   +1 more source

Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis

open access: yesPharmaceuticals
Background/Objectives: Antibody light chains form amyloid fibrils that lead to progressive tissue damage in amyloid light chain (AL) amyloidosis. The properties of each patient’s unique light chain appear to determine its propensity to form amyloid.
Gareth J. Morgan   +4 more
doaj   +1 more source

Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type [PDF]

open access: yes, 2017
Background. Renal amyloidosis results from protein misfolding and leads to progressive renal insufficiency. Few data are available concerning the relevance of the histomorphological patterns and the dynamics of the disease process. Methods.
Hopfer, Helmut   +2 more
core  

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis [PDF]

open access: gold, 2022
Μαρία Παπαθανασίου   +12 more
openalex   +1 more source

SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?

open access: yes
European Journal of Clinical Investigation, Volume 55, Issue 11, November 2025.
Flavio Tangianu   +3 more
wiley   +1 more source

Left Ventricular Structure and Function in Transthyretin-Related Versus Light-Chain Cardiac Amyloidosis

open access: green, 2014
Candida Cristina Quarta   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy